DNLI Competitors & Alternatives
Compare Denali Therapeutics Inc with similar stocks in the same industry
Biotechnology
DNLI
Main Stock$23.95
Tradestie Score
67
Market Cap
$2.18B
Revenue Growth
-1.0%
Analyst Upside
+41.7%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$17.91
|
$3.83B | - | 55 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$17.16
|
$3.68B | - | 51 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$103.54
|
$3.67B | - | 57 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.53
|
$3.59B | 12.1 | 55 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$21.71
|
$3.58B | 9.6 | 52 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$266.64
|
$3.49B | 33.0 | 62 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.11
|
$3.40B | - | 61 | Compare |
|
QURE
uniQure N.V.
|
$47.06
|
$3.39B | - | 57 | Compare |
|
SRRK
Scholar Rock Holding Corporation Common Stock
|
$47.65
|
$3.33B | - | 53 | Compare |
|
NAMS
NewAmsterdam Pharma Company N.V. Ordinary Shares
|
$30.34
|
$3.31B | - | 48 | Compare |
More DNLI Analysis
Data updated: Jun 17, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry